Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Neoplasms 1Nalbuphine Allergy 1Mouth Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Emergence Delirium 1Chronic Pain 1Breast Neoplasms 1

Interventions

Cisplatin 30Magnetic Resonance Spectroscopy 21Radiotherapy 20pembrolizumab 18Specimen Handling 17Cetuximab 16Biopsy 13Radiotherapy, Intensity-Modulated 12Radiation 11Paclitaxel 11Carboplatin 11Surveys and Questionnaires 10Fluorouracil 10Drug Therapy 101,2-diaminocyclohexaneplatinum II citrate 10Platinum 9Surgical Procedures, Operative 8X-Rays 7Taxes 7Celecoxib 7Standard of Care 6Sentinel Lymph Node Biopsy 6Observation 5Nivolumab 5cemiplimab 4Metformin 4Interviews as Topic 4Immunohistochemistry 4Fluorodeoxyglucose F18 4Docetaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mouth Neoplasms × Nalbuphine × Clear all
NCT07401641 2026-02-10

Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
60 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡